Literature DB >> 1186122

Gentamicin nephrotoxicity in rats. I. Acute biochemical and ultrastructural effects.

J Vera-Roman, T P Krishnakantha, F E Cuppage.   

Abstract

This investigation characterizes the acute biochemical and ultrastructural alterations within the rat kidney following the single injection of 10, 40, 80, or 160 mg. of gentamicin per kilogram of rat weight. Gentamicin was given intraperitoneally and rats were killed 80 minutes later. To assess a possible inhibitory effect upon protein synthesis 3H-leucine was injected 20 minutes postantibiotic and renal cortex was assayed for whole tissue and the protein fraction amino acid uptake. To exclude the possibility of gentamicin-induced lysosomal membrane instability with subsequent release of acid hydrolases, the activity of acid phosphatase was assayed in the supernatant and the residue of cortical homogenates containing the lysosomal fraction. Ultrastructural changes were concomitantly studied. To determine the intracellular localization of gentamicin, levels of the antibiotic were measured in subcellular fractions of cortical homogenates obtained from rats 2 hours following a single subcutaneous injection of 20 mg. of gentamicin per kilogram of rat weight. No gentamicin-induced alterations either of protein synthesis or of acid phosphatase distribution were demonstrated. Ultrastructural changes were most marked at 160 mg. per kg. consisting mainly of dilation of the endoplasmic reticulum, altered mitochondria, and increased cytosegresomes. Significant quantities of gentamicin were distributed within the nuclear, mitochondrial, and microsomal fractions. These studies indicate that although cytoplasmic alterations are prominent within the proximal tubular epithelial cells, they are not likely the result of either inhibition of protein synthesis or release of acid phosphatase from lysosomes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1186122

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Qualitative and quantitative preservation of the fine structure of absorptive cells in cultured biopsies of human small-intestine.

Authors:  L A Ginsel; J J van der Want; W T Daems
Journal:  Cell Tissue Res       Date:  1977-07-11       Impact factor: 5.249

2.  Light- and electron-microscopic analysis of the kidney in newborn rats exposed to gentamicin in utero.

Authors:  T Gilbert; B Nabarra; C Merlet-Bénichou
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

3.  The renal handling of polybasic drugs. 1. Gentamicin and aprotinin in intact animals.

Authors:  M Just; G Erdmann; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

4.  Metabolic abnormalities associated with tobramycin therapy.

Authors:  A J Watson; M M Watson; J A Keogh
Journal:  Ir J Med Sci       Date:  1984-03       Impact factor: 1.568

5.  Tetany following aminoglycoside therapy.

Authors:  A J Watson; S R McCann; I J Temperley
Journal:  Ir J Med Sci       Date:  1981-10       Impact factor: 1.568

6.  Acute interstitial nephritis associated with gentamicin and lincomycin therapy.

Authors:  G M Bell; D Thomson
Journal:  Postgrad Med J       Date:  1980-06       Impact factor: 2.401

Review 7.  Immediate and long-term renal effects of fetal exposure to gentamicin.

Authors:  T Gilbert; M Lelievre-Pegorier; C Merlet-Benichou
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

8.  Comparative nephrotoxicity of gentamicin and tobramycin in rats.

Authors:  D N Gilbert; C Plamp; P Starr; W M Bennet; D C Houghton; G Porter
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

9.  Autoradiographic localization of [3H]gentamicin in the proximal renal tubules of mice.

Authors:  M J Kuhar; L L Mak; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

10.  The effect of frusemide and piretanide on the renal clearance of gentamicin in man.

Authors:  P H Whiting; H E Barber; J Petersen
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.